Bit Capital Gmb H Blueprint Medicines Corp Call Options Transaction History
Bit Capital Gmb H
- $1.26 Trillion
- Q4 2024
Call Options
1 transactions
Others Institutions Holding BPMC
# of Institutions
362Shares Held
61.8MCall Options Held
2.24MPut Options Held
1.15M-
Vanguard Group Inc Valley Forge, PA6.77MShares$688 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$675 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$547 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$435 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$281 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.07B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...